<< Health professionals worry about ethnic sensitivity | Monitoring of a common epilepsy drug during pregnancy reduces seizure risk >>
Read in | English | Español | Français | Deutsch | 日本語 | 한국어 | हिन्दी

MicroRNA switches off tumor protection

Published on November 29, 2007 at 12:08 PM · No Comments

The microRNA miR-21 suppresses the production of tumor suppressor Pdcd4, which protects cells from cancer development.

Researchers at the DKFZ have now found out that colorectal cancer cells, in particular, lack Pdcd4, while these cells have an oversupply of miR-21, which promotes the spread of malignant tumors in the intestine.

It is not so long ago that microRNAs were discovered. Only a couple of years ago scientists found out how these tiny molecules – short transcripts of the hereditary substance, DNA – take part in the regulation of life in a cell: They bind to other DNA transcripts that are necessary for the production of proteins. The binding of microRNA leads to blocking or even degradation of these protein building instructions, before these can even be used for protein production. In this way, the cell controls the type and amount of proteins produced.

If this natural self-control of the cell is overactive, it can also cause damage by blocking the production of useful proteins. This is exactly what happens to the Pdcd4 protein in colorectal cancer cells, as reported in a recent study by the Clinical Cooperation Unit “Molecular Oncology of Solid Tumors” of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). Pdcd4 is what is called a tumor suppressor: It protects cells from transforming into cancer cells. If the substance disappears from a cell, cancer risk increases. A research team headed by Dr. Heike Allgayer has found out that the microRNA miR-21 in colorectal cancer cells suppresses the production of Pdcd4.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading